UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA

Lees, AJ; Ferreira, J; Rascol, O; Reichmann, H; Stocchi, F; Tolosa, E; Poewe, W; (2017) Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA. Expert Review of Neurotherapeutics , 17 (7) pp. 649-659. 10.1080/14737175.2017.1336086. Green open access

[thumbnail of Lees_Opicapone fo the management of end of dose motor fluctuations.pdf]
Preview
Text
Lees_Opicapone fo the management of end of dose motor fluctuations.pdf - Accepted Version

Download (526kB) | Preview

Abstract

INTRODUCTION: Opicapone is a third generation, highly potent and effective catechol O‑methyltransferase (COMT) inhibitor that optimizes the pharmacokinetics and bioavailability of L-DOPA therapy. AREAS COVERED: In this review, the authors describe the preclinical and clinical development of opicapone. In PD patients with motor fluctuations, once daily opicapone administration was well-tolerated and consistently reduced OFF-time and increased ON-time without increasing the frequency of troublesome dyskinesia, and these benefits were maintained over at least a year of continued open-label therapy. EXPERT COMMENTARY: With its convenient once-daily regimen, adjunct opicapone should be considered as an effective option for use in L-DOPA treated PD patients experiencing motor fluctuations.

Type: Article
Title: Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1080/14737175.2017.1336086
Publisher version: http://doi.org/10.1080/14737175.2017.1336086
Language: English
Additional information: © 2017 Informa UK Limited, trading as Taylor & Francis Group. This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: COMT inhibition, L-DOPA, Opicapone, Parkinson’s disease, motor fluctuations, wearing-off
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: https://discovery.ucl.ac.uk/id/eprint/1561137
Downloads since deposit
644Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item